Last 12 months
Inside the activity.
2 purchase rows · 5 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 2 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 01, 2026 Filed Sep 3, 2026 21:29 UTC |
Chan MitchellChief Financial Officer
|
Tax withholdingCommon Stock | 4,902 | $9.32 | $45,686.64 |
DisclosureSEC source: 0001789335-26-000008 · primarydocument.xml · nonDerivative · entry 1 Chan Mitchell · CIK 0001789335 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 122,815 F1 · shares: Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on September 16, 2024. The number of shares withheld was determined based on the closing price of the issuer's common stock on September 1, 2026. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 21:30 UTC |
Malzahn CraigChief Technology Officer
|
Tax withholdingCommon Stock | 234 | $9.32 | $2,180.88 |
DisclosureSEC source: 0002062007-26-000005 · primarydocument.xml · nonDerivative · entry 1 Malzahn Craig · CIK 0002062007 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,960 F1 · shares: Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on September 1, 2022. The number of shares withheld was determined based on the closing price of the issuer's common stock on September 1, 2026. Read SEC document |
| August 27, 2026 Filed Aug 27, 2026 23:03 UTC |
Ciongoli Gregory AustinDirector
|
PurchaseCommon Stock | 53,407 | $9.36 | $499,675.89 |
DisclosureSEC source: 0002023732-26-000008 · primarydocument.xml · nonDerivative · entry 3 Ciongoli Gregory Austin · CIK 0002023732 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,035 F3 · price: Represents shares purchased in an open-market transaction. The price reported in Column 4 is a weighted average price. This transaction was executed in multiple trades at prices ranging from $9.17 to $9.4525. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 26, 2026 Filed Aug 27, 2026 23:03 UTC |
Ciongoli Gregory AustinDirector
|
PurchaseCommon Stock | 49,196 | $9.14 | $449,705.56 |
DisclosureSEC source: 0002023732-26-000008 · primarydocument.xml · nonDerivative · entry 2 Ciongoli Gregory Austin · CIK 0002023732 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,628 F2 · price: Represents shares purchased in an open-market transaction. The price reported in Column 4 is a weighted average price. This transaction was executed in multiple trades at prices ranging from $8.67 to $9.35. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 25, 2026 Filed Aug 27, 2026 23:03 UTC |
Ciongoli Gregory AustinDirector
|
GrantStock Options (Right to buy) · Derivative | 69,609 | $0.00 Strike: $8.91 | $0.00 |
DisclosureSEC source: 0002023732-26-000008 · primarydocument.xml · derivative · entry 4 Ciongoli Gregory Austin · CIK 0002023732 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,609 Underlying: Common Stock · 69,609 shares Expires 2036-08-25 F4 · derivative.exercise_date: The option will vest over a three year period, with 1/3rd of the option vesting on August 25, 2027 and the remaining portion of the option vesting in equal monthly installments over the 24 months thereafter, while the optionee provides continuous service to the Issuer. Read SEC document |
| August 25, 2026 Filed Aug 27, 2026 23:03 UTC |
Ciongoli Gregory AustinDirector
|
GrantCommon Stock | 15,432 | $0.00 | $0.00 |
DisclosureSEC source: 0002023732-26-000008 · primarydocument.xml · nonDerivative · entry 1 Ciongoli Gregory Austin · CIK 0002023732 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,432 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 1/3rd of the shares subject to the RSU award shall vest on each of August 25, 2027, August 25, 2028 and August 25, 2029, while the recipient provides continuous service to the Issuer. Read SEC document |
| August 01, 2026 Filed Aug 4, 2026 20:30 UTC |
PAKOLA STEVEChief Medical Officer
|
Tax withholdingCommon Stock | 7,468 | $9.69 | $72,364.92 |
DisclosureSEC source: 0001700659-26-000016 · primarydocument.xml · nonDerivative · entry 1 PAKOLA STEVE · CIK 0001700659 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 205,541 F1 · shares: Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on August 1, 2024. The number of shares withheld was determined based on the closing price of the issuer's common stock on August 1, 2026. Read SEC document |
| August 01, 2026 Filed Aug 4, 2026 20:29 UTC |
Christmas Patrick J.Chief Strategy & Legal Officer
|
Tax withholdingCommon Stock | 4,699 | $9.69 | $45,533.31 |
DisclosureSEC source: 0001521123-26-000008 · primarydocument.xml · nonDerivative · entry 1 Christmas Patrick J. · CIK 0001521123 · Chief Strategy & Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 205,968 F1 · shares: Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on August 1, 2024. The number of shares withheld was determined based on the closing price of the issuer's common stock on August 1, 2026. Read SEC document |
| July 02, 2026 Filed Jul 6, 2026 20:51 UTC |
PAKOLA STEVEChief Medical Officer
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 2,161 | $0.00 Strike: $7.86 | $0.00 |
DisclosureSEC source: 0001700659-26-000014 · primarydocument.xml · derivative · entry 3 PAKOLA STEVE · CIK 0001700659 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 64,812 Underlying: Common Stock · 2,161 shares Expires 2035-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 103,698 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 2, 2026, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer. Read SEC document |
| July 02, 2026 Filed Jul 6, 2026 20:51 UTC |
PAKOLA STEVEChief Medical Officer
|
SaleCommon Stock | 2,161 | $13.64 | $29,476.04 |
DisclosureSEC source: 0001700659-26-000014 · primarydocument.xml · nonDerivative · entry 2 PAKOLA STEVE · CIK 0001700659 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 213,009 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| July 02, 2026 Filed Jul 6, 2026 20:51 UTC |
PAKOLA STEVEChief Medical Officer
|
Exercise / conversionCommon Stock | 2,161 | $7.86 | $16,985.46 |
DisclosureSEC source: 0001700659-26-000014 · primarydocument.xml · nonDerivative · entry 1 PAKOLA STEVE · CIK 0001700659 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 215,170 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 00:08 UTC |
PAKOLA STEVEChief Medical Officer
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 36,725 | $0.00 Strike: $7.86 | $0.00 |
DisclosureSEC source: 0001700659-26-000012 · primarydocument.xml · derivative · entry 4 PAKOLA STEVE · CIK 0001700659 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,973 Underlying: Common Stock · 36,725 shares Expires 2035-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 103,698 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 2, 2026, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 00:08 UTC |
PAKOLA STEVEChief Medical Officer
|
SaleCommon Stock | 36,725 | $12.86 | $472,283.50 |
DisclosureSEC source: 0001700659-26-000012 · primarydocument.xml · nonDerivative · entry 3 PAKOLA STEVE · CIK 0001700659 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 213,009 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 00:08 UTC |
PAKOLA STEVEChief Medical Officer
|
Exercise / conversionCommon Stock | 36,725 | $7.86 | $288,658.50 |
DisclosureSEC source: 0001700659-26-000012 · primarydocument.xml · nonDerivative · entry 2 PAKOLA STEVE · CIK 0001700659 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 249,734 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 20:51 UTC |
Simpson CurranDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 6,818 | $13.09 | $89,247.62 |
DisclosureSEC source: 0001346164-26-000006 · primarydocument.xml · nonDerivative · entry 3 Simpson Curran · CIK 0001346164 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 338,053 F5 · shares: Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on July 1, 2024. The number of shares withheld was determined based on the closing price of the issuer's common stock on July 1, 2026. Read SEC document |
| June 30, 2026 Filed Jul 6, 2026 20:51 UTC |
Simpson CurranDirector · Chief Executive Officer
|
GrantCommon Stock | 1,453 | $10.18 | $14,791.54 |
DisclosureSEC source: 0001346164-26-000006 · primarydocument.xml · nonDerivative · entry 2 Simpson Curran · CIK 0001346164 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 344,871 F3 · security: The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the ESPP for the ESPP purchase period of January 1, 2026 through June 30, 2026. This transaction is exempt under Rule 16b-3(c). F4 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on June 30, 2026. Read SEC document |
| June 29, 2026 Filed Jul 2, 2026 00:08 UTC |
PAKOLA STEVEChief Medical Officer
|
SaleCommon Stock | 19,608 | $11.04 | $216,472.32 |
DisclosureSEC source: 0001700659-26-000012 · primarydocument.xml · nonDerivative · entry 1 PAKOLA STEVE · CIK 0001700659 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 213,009 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $11.00 to $11.18. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 21:15 UTC |
Bennett JeanDirector
|
GrantStock Options (Right to Buy) · Derivative | 46,600 | $0.00 Strike: $7.01 | $0.00 |
DisclosureSEC source: 0001872219-26-000001 · primarydocument.xml · derivative · entry 2 Bennett Jean · CIK 0001872219 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,600 Underlying: Common Stock · 46,600 shares Expires 2036-05-29 F2 · derivative.exercise_date: The option will vest on May 29, 2027 subject to the continuous service of the optionee to the Issuer. Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 21:15 UTC |
Bennett JeanDirector
|
GrantCommon Stock | 9,807 | $0.00 | $0.00 |
DisclosureSEC source: 0001872219-26-000001 · primarydocument.xml · nonDerivative · entry 1 Bennett Jean · CIK 0001872219 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,861 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 29, 2027 subject to the continuous service of the recipient to the Issuer. Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 21:16 UTC |
MIGAUSKY GEORGE VDirector
|
GrantStock Options (Right to Buy) · Derivative | 46,600 | $0.00 Strike: $7.01 | $0.00 |
DisclosureSEC source: 0001134365-26-000001 · primarydocument.xml · derivative · entry 2 MIGAUSKY GEORGE V · CIK 0001134365 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,600 Underlying: Common Stock · 46,600 shares Expires 2036-05-29 F2 · derivative.exercise_date: The option will vest on May 29, 2027 subject to the continuous service of the optionee to the Issuer. Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 21:16 UTC |
MIGAUSKY GEORGE VDirector
|
GrantCommon Stock | 9,807 | $0.00 | $0.00 |
DisclosureSEC source: 0001134365-26-000001 · primarydocument.xml · nonDerivative · entry 1 MIGAUSKY GEORGE V · CIK 0001134365 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,861 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 29, 2027 subject to the continuous service of the recipient to the Issuer. Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 21:20 UTC |
Zachary JenniferDirector
|
GrantStock Options (Right to Buy) · Derivative | 46,600 | $0.00 Strike: $7.01 | $0.00 |
DisclosureSEC source: 0001737231-26-000002 · primarydocument.xml · derivative · entry 2 Zachary Jennifer · CIK 0001737231 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,600 Underlying: Common Stock · 46,600 shares Expires 2036-05-29 F2 · derivative.exercise_date: The option will vest on May 29, 2027 subject to the continuous service of the optionee to the Issuer. Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 21:20 UTC |
Zachary JenniferDirector
|
GrantCommon Stock | 9,807 | $0.00 | $0.00 |
DisclosureSEC source: 0001737231-26-000002 · primarydocument.xml · nonDerivative · entry 1 Zachary Jennifer · CIK 0001737231 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,871 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 29, 2027 subject to the continuous service of the recipient to the Issuer. Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 21:16 UTC |
Glucksmann AlexandraDirector
|
GrantStock Options (Right to Buy) · Derivative | 46,600 | $0.00 Strike: $7.01 | $0.00 |
DisclosureSEC source: 0001658390-26-000001 · primarydocument.xml · derivative · entry 2 Glucksmann Alexandra · CIK 0001658390 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,600 Underlying: Common Stock · 46,600 shares Expires 2036-05-29 F2 · derivative.exercise_date: The option will vest on May 29, 2027 subject to the continuous service of the optionee to the Issuer. Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 21:16 UTC |
Glucksmann AlexandraDirector
|
GrantCommon Stock | 9,807 | $0.00 | $0.00 |
DisclosureSEC source: 0001658390-26-000001 · primarydocument.xml · nonDerivative · entry 1 Glucksmann Alexandra · CIK 0001658390 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,861 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 29, 2027 subject to the continuous service of the recipient to the Issuer. Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 21:15 UTC |
Fox Allan M.Director
|
GrantStock Options (Right to Buy) · Derivative | 46,600 | $0.00 Strike: $7.01 | $0.00 |
DisclosureSEC source: 0001652936-26-000001 · primarydocument.xml · derivative · entry 6 Fox Allan M. · CIK 0001652936 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,600 Underlying: Common Stock · 46,600 shares Expires 2036-05-29 F3 · derivative.exercise_date: The option will vest on May 29, 2027 subject to the continuous service of the optionee to the Issuer. Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 21:15 UTC |
Fox Allan M.Director
|
GrantCommon Stock | 9,807 | $0.00 | $0.00 |
DisclosureSEC source: 0001652936-26-000001 · primarydocument.xml · nonDerivative · entry 1 Fox Allan M. · CIK 0001652936 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,861 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 29, 2027 subject to the continuous service of the recipient to the Issuer. Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 21:16 UTC |
Mills Kenneth T.Director
|
GrantStock Options (Right to Buy) · Derivative | 46,600 | $0.00 Strike: $7.01 | $0.00 |
DisclosureSEC source: 0001652824-26-000003 · primarydocument.xml · derivative · entry 2 Mills Kenneth T. · CIK 0001652824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,600 Underlying: Common Stock · 46,600 shares Expires 2036-05-29 F2 · derivative.exercise_date: The option will vest May 29, 2027 subject to the continuous service of the optionee to the Issuer. Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 21:16 UTC |
Mills Kenneth T.Director
|
GrantCommon Stock | 9,807 | $0.00 | $0.00 |
DisclosureSEC source: 0001652824-26-000003 · primarydocument.xml · nonDerivative · entry 1 Mills Kenneth T. · CIK 0001652824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 495,925 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 29, 2027 subject to the continuous service of the recipient to the Issuer. Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 21:20 UTC |
STUMP DAVID CDirector
|
GrantStock Options (Right to Buy) · Derivative | 46,600 | $0.00 Strike: $7.01 | $0.00 |
DisclosureSEC source: 0001191235-26-000003 · primarydocument.xml · derivative · entry 2 STUMP DAVID C · CIK 0001191235 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,600 Underlying: Common Stock · 46,600 shares Expires 2036-05-29 F2 · derivative.exercise_date: The option will vest on May 29, 2027 subject to the continuous service of the optionee to the Issuer. Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 21:20 UTC |
STUMP DAVID CDirector
|
GrantCommon Stock | 9,807 | $0.00 | $0.00 |
DisclosureSEC source: 0001191235-26-000003 · primarydocument.xml · nonDerivative · entry 1 STUMP DAVID C · CIK 0001191235 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,861 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 29, 2027 subject to the continuous service of the recipient to the Issuer. Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 21:16 UTC |
KARABELAS ARGERIS NDirector
|
GrantStock Options (Right to Buy) · Derivative | 46,600 | $0.00 Strike: $7.01 | $0.00 |
DisclosureSEC source: 0001191229-26-000002 · primarydocument.xml · derivative · entry 2 KARABELAS ARGERIS N · CIK 0001191229 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,600 Underlying: Common Stock · 46,600 shares Expires 2036-05-29 F2 · derivative.exercise_date: The option will vest in 12 equal monthly installments following May 29, 2027 subject to the continuous service of the optionee to the Issuer. Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 21:16 UTC |
KARABELAS ARGERIS NDirector
|
GrantCommon Stock | 9,807 | $0.00 | $0.00 |
DisclosureSEC source: 0001191229-26-000002 · primarydocument.xml · nonDerivative · entry 1 KARABELAS ARGERIS N · CIK 0001191229 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,861 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 29, 2027 subject to the continuous service of the recipient to the Issuer. Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 21:21 UTC |
Tasse DanielDirector
|
GrantStock Options (Right to Buy) · Derivative | 46,600 | $0.00 Strike: $7.01 | $0.00 |
DisclosureSEC source: 0001502785-26-000001 · primarydocument.xml · derivative · entry 2 Tasse Daniel · CIK 0001502785 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,600 Underlying: Common Stock · 46,600 shares Expires 2036-05-29 F2 · derivative.exercise_date: The option will vest on May 29, 2027 subject to the continuous service of the optionee to the Issuer. Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 21:21 UTC |
Tasse DanielDirector
|
GrantCommon Stock | 9,807 | $0.00 | $0.00 |
DisclosureSEC source: 0001502785-26-000001 · primarydocument.xml · nonDerivative · entry 1 Tasse Daniel · CIK 0001502785 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,861 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 29, 2027 subject to the continuous service of the recipient to the Issuer. Read SEC document |
| May 11, 2026 Filed May 13, 2026 21:18 UTC |
PAKOLA STEVEChief Medical Officer
|
SaleCommon Stock | 15,309 | $11.02 | $168,705.18 |
DisclosureSEC source: 0001700659-26-000010 · primarydocument.xml · nonDerivative · entry 1 PAKOLA STEVE · CIK 0001700659 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 232,617 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $11.00 to $11.10. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 22:17 UTC |
PAKOLA STEVEChief Medical Officer
|
SaleCommon Stock | 5,124 | $10.35 | $53,033.40 |
DisclosureSEC source: 0001700659-26-000008 · primarydocument.xml · nonDerivative · entry 1 PAKOLA STEVE · CIK 0001700659 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 247,926 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:46 UTC |
PAKOLA STEVEChief Medical Officer
|
Tax withholdingCommon Stock | 5,267 | $11.16 | $58,779.72 |
DisclosureSEC source: 0001700659-26-000006 · primarydocument.xml · nonDerivative · entry 1 PAKOLA STEVE · CIK 0001700659 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 253,050 F1 · shares: Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on August 1, 2024. The number of shares withheld was determined based on the closing price of the issuer's common stock on February 1, 2026. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:47 UTC |
Christmas Patrick J.Chief Strategy & Legal Officer
|
Tax withholdingCommon Stock | 4,700 | $11.16 | $52,452.00 |
DisclosureSEC source: 0001521123-26-000006 · primarydocument.xml · nonDerivative · entry 1 Christmas Patrick J. · CIK 0001521123 · Chief Strategy & Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 210,667 F1 · shares: Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on August 1, 2024. The number of shares withheld was determined based on the closing price of the issuer's common stock on February 1, 2026. Read SEC document |
| January 27, 2026 Filed Jan 29, 2026 21:58 UTC |
Mills Kenneth T.Director
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 225,000 | $0.00 Strike: $13.09 | $0.00 |
DisclosureSEC source: 0001652824-26-000002 · primarydocument.xml · derivative · entry 3 Mills Kenneth T. · CIK 0001652824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 225,000 Underlying: Common Stock · 225,000 shares Expires 2026-01-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 225,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 28, 2017, and the balance vested in equal monthly installments over the 36 months thereafter. Read SEC document |
| January 27, 2026 Filed Jan 29, 2026 21:58 UTC |
Mills Kenneth T.Director
|
Tax withholdingCommon Stock | 221,753 | $13.41 | $2,973,707.73 |
DisclosureSEC source: 0001652824-26-000002 · primarydocument.xml · nonDerivative · entry 2 Mills Kenneth T. · CIK 0001652824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 486,118 F2 · kind: Represents shares of common stock withheld to satisfy the exercise price and pay taxes upon the exercise of options originally granted to the reporting person on January 28, 2016, which were set to expire on January 28, 2026. The number of shares withheld was determined based on the closing price of the issuer's common stock on January 27, 2026. The transaction did not involve any open-market sale of securities. Read SEC document |
| January 27, 2026 Filed Jan 29, 2026 21:58 UTC |
Mills Kenneth T.Director
|
Exercise / conversionCommon Stock | 225,000 | $13.09 | $2,945,250.00 |
DisclosureSEC source: 0001652824-26-000002 · primarydocument.xml · nonDerivative · entry 1 Mills Kenneth T. · CIK 0001652824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 707,871 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The previously granted option, representing a right to purchase a total of 225,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 28, 2017, and the balance vested in equal monthly installments over the 36 months thereafter. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 16:43 UTC |
Malzahn CraigChief Technology Officer
|
GrantStock Options (Right to buy) · Derivative | 35,402 | $0.00 Strike: $14.18 | $0.00 |
DisclosureSEC source: 0002062007-26-000003 · primarydocument.xml · derivative · entry 2 Malzahn Craig · CIK 0002062007 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,402 Underlying: Common Stock · 35,402 shares Expires 2036-01-06 F2 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 6, 2027 while the optionee provides continuous service to the Issuer. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 16:43 UTC |
Malzahn CraigChief Technology Officer
|
GrantCommon Stock | 65,847 | $0.00 | $0.00 |
DisclosureSEC source: 0002062007-26-000003 · primarydocument.xml · nonDerivative · entry 1 Malzahn Craig · CIK 0002062007 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,194 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 6, 2027, January 6, 2028, January 6, 2029 and January 6, 2030 while the recipient provides continuous service to the Issuer. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 21:44 UTC |
PAKOLA STEVEChief Medical Officer
|
GrantStock Options (Right to buy) · Derivative | 35,402 | $0.00 Strike: $14.18 | $0.00 |
DisclosureSEC source: 0001700659-26-000004 · primarydocument.xml · derivative · entry 2 PAKOLA STEVE · CIK 0001700659 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,402 Underlying: Common Stock · 35,402 shares Expires 2036-01-06 F2 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 6, 2027 while the optionee provides continuous service to the Issuer. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 21:44 UTC |
PAKOLA STEVEChief Medical Officer
|
GrantCommon Stock | 65,847 | $0.00 | $0.00 |
DisclosureSEC source: 0001700659-26-000004 · primarydocument.xml · nonDerivative · entry 1 PAKOLA STEVE · CIK 0001700659 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 258,317 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 6, 2027, January 6, 2028, January 6, 2029 and January 6, 2030 while the recipient provides continuous service to the Issuer. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 21:43 UTC |
Simpson CurranDirector · Chief Executive Officer
|
GrantStock Options (Right to buy) · Derivative | 233,651 | $0.00 Strike: $14.18 | $0.00 |
DisclosureSEC source: 0001346164-26-000004 · primarydocument.xml · derivative · entry 2 Simpson Curran · CIK 0001346164 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 233,651 Underlying: Common Stock · 233,651 shares Expires 2036-01-06 F2 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 6, 2027 while the optionee provides continuous service to the Issuer. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 21:43 UTC |
Simpson CurranDirector · Chief Executive Officer
|
GrantCommon Stock | 144,864 | $0.00 | $0.00 |
DisclosureSEC source: 0001346164-26-000004 · primarydocument.xml · nonDerivative · entry 1 Simpson Curran · CIK 0001346164 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 342,467 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 6, 2027, January 6, 2028, January 6, 2029 and January 6, 2030 while the recipient provides continuous service to the Issuer. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 21:39 UTC |
Christmas Patrick J.Chief Strategy & Legal Officer
|
GrantStock Options (Right to buy) · Derivative | 39,650 | $0.00 Strike: $14.18 | $0.00 |
DisclosureSEC source: 0001521123-26-000004 · primarydocument.xml · derivative · entry 2 Christmas Patrick J. · CIK 0001521123 · Chief Strategy & Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,650 Underlying: Common Stock · 39,650 shares Expires 2036-01-06 F2 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 6, 2027 while the optionee provides continuous service to the Issuer. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 21:39 UTC |
Christmas Patrick J.Chief Strategy & Legal Officer
|
GrantCommon Stock | 73,749 | $0.00 | $0.00 |
DisclosureSEC source: 0001521123-26-000004 · primarydocument.xml · nonDerivative · entry 1 Christmas Patrick J. · CIK 0001521123 · Chief Strategy & Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 215,367 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 6, 2027, January 6, 2028, January 6, 2029 and January 6, 2030 while the recipient provides continuous service to the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.